NurExone Biologic Inc. (TSXV:NRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.6600
-0.0200 (-2.94%)
May 9, 2025, 4:00 PM EDT
11.86%
Market Cap 51.49M
Revenue (ttm) n/a
Net Income (ttm) -7.26M
Shares Out 78.01M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,728
Average Volume 11,070
Open 0.6700
Previous Close 0.6800
Day's Range 0.6600 - 0.6700
52-Week Range 0.4600 - 0.8700
Beta 0.02
RSI 47.26
Earnings Date May 27, 2025

About NurExone Biologic

NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing and commercializing the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. Its technology includes ExoPTEN, for acute spinal cord injury, and glaucom... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.